|
ARVs  CIPLA-DUOVIR Tablets
 Reg. No. A40/20.2.8/0244Zidovudine 300 mg, Lamivudine 150 mg Pack: 60's  CIPLA-EFAVIRENZ 600 Tablets
Reg. No. 41/20.2.8/0106Efavirenz 600 mg Pack: 30's   CIPLA-LAMIVUDINE Oral Solution
Reg. No. 37/20.2.8/0615Lamivudine 50 mg / 5 ml Pack: 100 ml / 240 ml  CIPLA-LAMIVUDINE Tablets
Reg. No. 35/20.2.8/0248Lamivudine 150 mg Pack: 60's  CIPLA-LAMIVUDINE 300 Tablets
Reg. No. 41/20.2.8/0140Lamivudine 300 mg Pack: 30's Cipla released South Africa’s first single tablet once-daily dosage of the antiretroviral lamivudine. This 300 mg dosage is as effective as the currently available twice daily dose of lamivudine 150 mg and carries the same safety profile. The private lamivudine market (excluding the sizeable state market) is worth R14 million.  CIPLA-NEVIRAPINE Oral Suspension
Reg. No. A38/20.2.8/0339Nevirapine 50 mg / 5 ml Pack: 240 ml  CIPLA-NEVIRAPINE Tablets
Reg. No. 36/20.2.8/0423Nevirapine 200 mg Pack: 60's  CIPLA-ZIDOVUDINE Capsules
Reg. No. 34/20.2.8/0142Zidovudine 100 mg Pack: 120's  CIPLA-ZIDOVUDINE Oral Solution
Reg. No. 37/20.2.8/0614Zidovudine 50 mg / 5 ml Pack: 100 ml / 240 ml  CIPLA-ZIDOVUDINE 300 Tablets
Reg. No. 38/20.2.8/0215Zidovudine 300 mg Pack: 60's  STAVIR 30/40 Capsules
Reg. No. 36/20.2.8/0300, 0301Stavudine 30 mg / 40 mg Pack: 60's  TRIOMUNE 30 / 40 Tablets
Reg. No. A38/20.2.8/0409, A40/20.2.8/0460 Lamivudine 150 mg + Stavudine 30 / 40 mg + Nevirapine 200 mg Pack: 60's |
ATOLIP |
CIPLATRIM |
FINPECIA |
NEXOMIST |
